Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Kleivi, Kristine"'
Autor:
Lindholm, Evita, Leivonen, Suvi-Katri, Undlien, Eldri, Nebdal, Daniel, Git, Anna, Caldas, Carlos, Borresen-Dale, Anne-Lise, Sahlberg, Kristine, Kleivi, Kristine
Publikováno v:
MicroRNA. 8:155-165
Background: HER2 positive Breast Cancers (BC) have aggressive behavior and poor prognosis. Previously, we have identified miR-342-5p as an upstream regulator of HER2 signaling, as well as inhibitor of HER2 positive BC cell line growth. Objective: Her
Autor:
Kleivi, Kristine, Teixeira, Manuel R., Eknæs, Mette, Diep, Chieu B., Jakobsen, Kjetill S., Hamelin, Richard, Lothe, Ragnhild A.
Publikováno v:
In Cancer Genetics and Cytogenetics 2004 155(2):119-131
Autor:
Kleivi Kristine, Wolf Maija, Edgren Henrik, Muggerud Aslaug, Dejeux Emelyne, Tost Jörg, Sørlie Therese, Kallioniemi Olli
Publikováno v:
BMC Medical Genomics, Vol 2, Iss 1, p 26 (2009)
Abstract Background Using array comparative genomic hybridization (aCGH), a large number of deleted genomic regions have been identified in human cancers. However, subsequent efforts to identify target genes selected for inactivation in these regions
Externí odkaz:
https://doaj.org/article/4bb690958573407a811c0d8695aaf493
Autor:
Myklebost Ola, Nesland Jahn M, Brandal Lin T, Meling Gunn I, Diep Chieu B, Lind Guro E, Kleivi Kristine, Rognum Torleiv O, Giercksky Karl-Erik, Skotheim Rolf I, Lothe Ragnhild A
Publikováno v:
Molecular Cancer, Vol 6, Iss 1, p 2 (2007)
Abstract Background Despite the fact that metastases are the leading cause of colorectal cancer deaths, little is known about the underlying molecular changes in these advanced disease stages. Few have studied the overall gene expression levels in me
Externí odkaz:
https://doaj.org/article/063f9c713988469398bda4c688fa0381
Autor:
Lind, Guro E.1, Kleivi, Kristine2, Meling, Gunn I.3, Teixeira, Manuel R.4, Thiis-Evensen, Espen5, Rognum, Torleiv O.6, Lothe, Ragnhild A.1,7 A.Lothe@rr-research.no
Publikováno v:
Cellular Oncology. Sep2006, Vol. 28 Issue 5/6, p259-272. 14p.
Autor:
Edgren, Henrik, Murumagi, Astrid, Kangaspeska, Sara, Nicorici, Daniel, Hongisto, Vesa, Kleivi, Kristine, Rye, Inga H, Nyberg, Sandra, Wolf, Maija, Borresen-Dale, Anne-Lise, Kallioniemi, Olli
Publikováno v:
Genome Biology. 2011 Jan 19;12(1):R6
Externí odkaz:
http://hdl.handle.net/10852/46857
https://www.duo.uio.no/bitstream/handle/10852/46857/1/13059_2010_Article_2471.pdf
https://www.duo.uio.no/bitstream/handle/10852/46857/1/13059_2010_Article_2471.pdf
Autor:
Leivonen, Suvi-Katri, Mäkelä, Rami, Östling, Päivi, Kohonen, Pekka, Haapa-Paananen, Saija, Aakula, Anna, Hellström, Kirsi, Sahlberg, Niko, Kleivi, Kristine, Enerly, Espen, Kristensen, Vessela N., Borresen-Dale, Anne-Lise, Saviranta, Petri, Perälä, Merja, Kallioniemi, Olli
Publikováno v:
Leivonen, S-K, Mäkelä, R, Östling, P, Kohonen, P, Haapa-Paananen, S, Aakula, A, Hellström, K, Sahlberg, N, Kleivi, K, Enerly, E, Kristensen, V N, Borresen-Dale, A-L, Saviranta, P, Perälä, M & Kallioniemi, O 2009, ' High-throughput functional screens and clinical profiling identify microRNAs regulating estrogen receptor (ER)-alfa signaling in breast cancer ', Paper presented at 100th Annual Meeting of the American Association for Cancer Research, Denver, United States, 18/04/09-22/04/09 .
MicroRNAs (miRNAs) regulate protein expression by targeting messenger RNAs (mRNAs) for cleavage or by inducing translational repression. In breast cancer, estrogen receptor-a (ERa) levels are critical for cancer cell growth, but our knowledge of miRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=355e65625b88::46194cf6ba7fd3013392f092101528d0
https://cris.vtt.fi/en/publications/be5af615-b563-462a-b271-740bc637fcdc
https://cris.vtt.fi/en/publications/be5af615-b563-462a-b271-740bc637fcdc
Autor:
Hellström, Kirsi, Kleivi, Kristine, Haapa-Paananen, Saija, Leivonen, Suvi-Katri, Pollari, Sirkku, Kohonen, Pekka, Iljin, Kristina, Edgren, Henrik, Wolf, Maija, Sahlberg, Niko, Rantala, Juha K., Mäkelä, Rami, Saviranta, Petri, Perälä, Merja, Kallioniemi, Olli
Publikováno v:
Hellström, K, Kleivi, K, Haapa-Paananen, S, Leivonen, S-K, Pollari, S, Kohonen, P, Iljin, K, Edgren, H, Wolf, M, Sahlberg, N, Rantala, J K, Mäkelä, R, Saviranta, P, Perälä, M & Kallioniemi, O 2008, ' High throughput RNAi screening and hit validation in breast cancer cell lines ', Paper presented at RNAi, MicroRNA, Non-Coding RNA, Whistler, Canada, 25/03/08-30/03/08 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=355e65625b88::c7e101c9b2e36ebed3a3e430ac0ce503
https://cris.vtt.fi/en/publications/eebecb70-5ca2-461f-905c-2512fd96f7d1
https://cris.vtt.fi/en/publications/eebecb70-5ca2-461f-905c-2512fd96f7d1
Autor:
Kleivi, Kristine, Lind, Guro E, Diep, Chieu B, Meling, Gunn I, Brandal, Lin T, Nesland, Jahn M, Myklebost, Ola, Rognum, Torleiv O, Giercksky, Karl-Erik, Skotheim, Rolf I, Lothe, Ragnhild A
Publikováno v:
Molecular Cancer. 2007 Jan 03;6(1):2
Externí odkaz:
http://hdl.handle.net/10852/46400
https://www.duo.uio.no/bitstream/handle/10852/46400/1/12943_2006_Article_210.pdf
https://www.duo.uio.no/bitstream/handle/10852/46400/1/12943_2006_Article_210.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.